Patent US4654360A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4654360A Expired / Lapsed US ⏱️ 0.0 years remaining

1,2,3-trisubstituted indoles for treatment of inflammation

Assignee: Syntex USA LLC
•
Filing: 1984-06-01
•
Granted: 1987-03-31
•
Expires: 2004-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are compounds of the formula ##STR1## wherein the several groups are defined herein. These compounds are useful for treating inflammation.

Inventors

  • 👤 Robert J. Greenhouse
  • 👤 Joseph M. Muchowski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 18:27
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D209/40

Claims Analysis

Total Claims: 29
Claim 1
Independent Claim 192 words
A compound of the formula: ##STR5## wherein R is alkyl of 1 to 8 carbon atoms, benzyl or benzyl substituted with one or more groups independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 , --SCN, and --OCH 2 O-- attached at adjacent carbon atoms, which is methylenedioxy; R 1 is hydrogen or alkyl of 1 to 4 carbon atoms; Y is S, NH, or NR 2 ; n is 2, 3, 4, 5, 6, 7, or 8; m is 0, 1 or 2; X and Z are independently alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 or --SCN; p is 0, 1, 2, 3, 4, or 5; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 192 words
A compound of the formula: ##STR5## wherein R is alkyl of 1 to 8 carbon atoms, benzyl or benzyl substituted with one or more groups independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 , --SCN, and --OCH 2 O-- attached at adjacent carbon atoms, which is methylenedioxy; R 1 is hydrogen or alkyl of 1 to 4 carbon atoms; Y is S, NH, or NR 2 ; n is 2, 3, 4, 5, 6, 7, or 8; m is 0, 1 or 2; X and Z are independently alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 or --SCN; p is 0, 1, 2, 3, 4, or 5; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 10 words
A compound according to claim 1 wherein Y is S.
Claim 4
Dependent Claim 16 words
A compound of claim 2 wherein n is 2, m is 2 and Z is hydrogen.
Claim 5
Dependent Claim 13 words
A compound according to claim 3 wherein R is benzyl or substituted benzyl.
Claim 6
Dependent Claim 15 words
A compound according to claim 4 which is 1-benzyl-2-aminoethylthio-3-phenylsulfonylindole or an acid addition salt thereof.
Claim 7
Dependent Claim 15 words
A compound according to claim 4 which is 1-(2-methoxycarbonylbenzyl)-2-aminoethylthio-3-phenylsulfonylindole or an acid addition salt thereof.
Claim 8
Dependent Claim 17 words
A compound according to claim 4 which is 1-(4-chlorobenzyl)-2-aminoethylthio-3-phenylsulfonylindole or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Dependent Claim 17 words
A compound according to claim 4 which is 1-(-4-methylbenzyl)-2-aminoethylthio-3-phenylsulfonylindole or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim 17 words
A compound according to claim 4 which is 1-benzyl-2-aminoethylthio-3-(4-methylphenylsulfonyl)indole or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim 17 words
A compound according to claim 4 which is 1-benzyl-2-aminoethylthio-3-(4-chlorophenylsulfonyl)indole or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Independent Claim 211 words
A method for treating inflammation, which method comprises administering either alone or in admixture with a pharmaceutically acceptable excipient, a compound of the formula ##STR6## wherein R is alkyl of 1 to 8 carbon atoms, benzyl or benzyl substituted with one or more groups independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 , CH 3 --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 , --SCN and --OCH 2 O-- attached at adjacent carbon atoms, which is methylenedioxy; R 1 is independently hydrogen or alkyl of 1 to 4 carbon atoms; Y is SO, NH, or NR 2 ; n is 2, 3, 4, 5, 6, 7, 8; m is 0, 1 or 2; X and Z are independently alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 or --SCN; p is 0, 1, 2, 3, 4 or 5; or a pharmaceutically acceptable salt thereof.
Claim 13
Independent Claim 211 words
A method for treating inflammation, which method comprises administering either alone or in admixture with a pharmaceutically acceptable excipient, a compound of the formula ##STR6## wherein R is alkyl of 1 to 8 carbon atoms, benzyl or benzyl substituted with one or more groups independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 , CH 3 --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 , --SCN and --OCH 2 O-- attached at adjacent carbon atoms, which is methylenedioxy; R 1 is independently hydrogen or alkyl of 1 to 4 carbon atoms; Y is SO, NH, or NR 2 ; n is 2, 3, 4, 5, 6, 7, 8; m is 0, 1 or 2; X and Z are independently alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 or --SCN; p is 0, 1, 2, 3, 4 or 5; or a pharmaceutically acceptable salt thereof.
Claim 14
Dependent Claim 9 words
The method of claim 11 wherein Y is S.
Claim 15
Dependent Claim 16 words
The method of claim 11 wherein n is 2, m is 2 and Z is hydrogen.
Claim 16
Dependent Claim 12 words
The method of claim 11 wherein R is benzyl or substituted benzyl.
Claim 17
Dependent Claim 20 words
The method of claim 11 in which the compound to be administered is 1-(2-methoxycarbonylbenzyl)-2-aminoethylthio-3-phenylsulfonylindole or an acid addition salt thereof.
Claim 18
Dependent Claim 22 words
The method of claim 11 in which the compound to be administered is 1-(4-chlorobenzyl)-2-aminoethylthio-3-phenylsulfonylindole or a pharmaceutically acceptable acid addition salt thereof.
Claim 19
Dependent Claim 22 words
The method of claim 11 in which the compound to be administered is 1-(-4-methylbenzyl)-2-aminoethylthio-3-phenylsulfonylindole or a pharmaceutically acceptable acid addition salt thereof.
Claim 20
Dependent Claim 22 words
The method of claim 11 in which the compound to be administered is 1-benzyl-2-aminoethylthio-3-(4-methylphenylsulfonyl)indole or a pharmaceutically acceptable acid addition salt thereof.
Claim 21
Dependent Claim 168 words
A compound of the formula: ##STR7## wherein R is alkyl of 1 to 8 carbon atoms, benzyl or benzyl substituted with one or more groups independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 , --SCN, and --OCH 2 O-- attached at adjacent carbon atoms, which is methylenedioxy; R 1 is hydrogen or alkyl of 1 to 4 carbon atoms m is 0, 1 or 2; X and Z are independently alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 or --SCN; p is 0, 1, 2, 3, 4, or 5.
Claim 22
Dependent Claim 168 words
A compound of the formula: ##STR7## wherein R is alkyl of 1 to 8 carbon atoms, benzyl or benzyl substituted with one or more groups independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 , --SCN, and --OCH 2 O-- attached at adjacent carbon atoms, which is methylenedioxy; R 1 is hydrogen or alkyl of 1 to 4 carbon atoms m is 0, 1 or 2; X and Z are independently alkyl of 1 to 4 carbon atoms, halo, hydroxy, --OR 2 where R 2 is alkyl of 1 to 4 carbon atoms, --OCF 3 , --SO 2 CH 3 , --CO 2 H, --CO 2 R 2 , --CHO, --NO 2 , --CF 3 or --SCN; p is 0, 1, 2, 3, 4, or 5.
Claim 23
Dependent Claim 9 words
A compound according to claim 19 which is 1-benzyl-2-chloro-3-phenylsulfosulfonylindole.
Claim 24
Dependent Claim 9 words
A compound according to claim 19 which is 1-benzyl-2-chloro-3-(4-methylphenylsulfonyl)indole.
Claim 25
Dependent Claim 9 words
A compound according to claim 19 which is 1-benzyl-2-chloro-3-(4-chlorphenylsulfonyl)indole.
Claim 26
Dependent Claim 9 words
A compound according to claim 19 which is 1-(4-chlorobenzyl)-2-chloro-3-phenylsulfonylindole.
Claim 27
Dependent Claim 9 words
A compound according to claim 19 which is 1-(2-methylcarbonylbenzyl)-2-chloro-3-phenylsulfonylindole.
Claim 28
Dependent Claim 9 words
A compound according to claim 19 which is 1-(4-methylbenzyl)-2-chloro-3-phenylsulfonylindole.
Claim 29
Dependent Claim 22 words
The method of claim 11 in which the compound to be administered is 1-benzyl-2-aminoethylthio-3-(4-chlorophenylsulfonyl)indole or a pharmaceutically acceptable acid addition salt thereof.

References Cited (Backward Citations)

US3441570A Cited
US3665016A Cited
US3489770A Cited
US3860609A Cited
US4428962A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-03-30 1990-09-29 1991-03-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-03-30 1994-09-29 1995-03-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-03-30 1998-09-29 1999-03-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag